Table 3

Systematic review and overall observed effects for metabolic parameters

StudyPopulationTraining programmeOutcomes
StatusGenderAge
(year)
Sample sizeDropout (n)Duration (weeks)Comparison group (n)Average intensity (%HRmax)Days/weekSession (min)LDL cholesterol
(mmol/L)
HDL cholesterol
(mmol/L)
Plasma triglycerides (mmol/L)Total cholesterol
(mmol/L)
Blood glucose
(mmol/L)
Glucose tolerance
(mmol/L)
Andersen et al 10 Type II diabetesM49±221324CG (n=9)83±21.5±0.960FG: 1.0 ↓*
CG: 0.9 ↑
Andersen et al 23 Mild to moderate hypertensionM31–5422312CG (n=9)831.7±0.260FG: nc
CG: nc
FG: nc
CG: 0.1↓
FG: 0.2 ↑
CG: nc
FG: nc*
CG: 0.5 ↓
Barene et al 26 Healthy hospital employeesF25–651184140ZG (n=30)
CG (n=34)
78.6±3.212 weeks: 2.4±0.5
28 weeks: 1.2±0.2
60FG: 0.1↓
ZG: 0.2↓
CG: nc
FG: nc
ZG: nc
CG: nc
FG: nc
ZG: 0.1↑
CG: nc
FG: nc
ZG: 0.2↓
CG: nc
FG: 0.1 ↑
ZG: 0.2 ↓
CG: nc
Krustrup et al 30 Healthy untrainedF19–4728668RG (n=8)
CG (n=7)
81±11.7860FG: 0.2 ↓
RG: nc
CG: 0.1 ↑
FG: 0.1 ↑
RG: 0.1 ↑
CG: 0.1 ↑
FG: 0.06 ↓
RG: 0.06 ↑
CG: 0.05 ↑
FG: 0.1 ↓
RG: 0.1 ↓
CG: 0.2 ↑
FG: nc
RG: 0.4 ↓
CG: 0.1 ↑
FG: 0.1 ↓
RG: 0.3 ↓
CG: 0.3 ↑
Krustrup et al 37 Healthy untrainedF19–47531216RG (n=18)
CG (n=14)
831.860FG: 0.1 ↓
RG: nc
CG: 0.3 ↓
Krustrup et al 5 Healthy untrainedM20–4336412RG (n=12)
CG (n=11)
822.360FG: 0.4 ↓
RG: 0.1 ↓
CG: nc
FG: 0.1↑
RG: 0.1↑
CG: 0.1↑
FG: 0.2 ↓
RG: 0.3 ↓
CG: nc
Krustrup et al 31 Untrained with mild hypertensionM30–55431026CG (n=11)85±71.7±0.560FG: 0.3 ↓
CG: 0.3 ↑
FG: 0.1 ↓
CG: 0.1 ↑
FG: nc
CG: 0.3 ↓
Mohr et al 9 Sedentary with mild hypertensionF35–5042115CG (n=20)80.5±1.13.0±0.160FG: nc
CG: nc
FG: nc
CG: nc
FG: 0.2 ↓
CG: 0.3 ↑
FG: 0.4 ↓
CG: 0.1 ↑
Randers et al 24 Healthy untrainedM20–4322512+52CG (n=7)12 weeks: 81
52 weeks: 82
12 weeks: 1.8–2.9
52 weeks: 0.9–1.6
60FG: 0.2 ↓
CG: 0.2 ↑
FG: 0.1 ↑
CG: nc
FG: 0.2 ↓
CG: 0.2 ↓
FG: nc
CG: 0.1 ↑
FG: 0.2 ↓
CG: nc
FG: 0.2 ↓
CG: 0.2 ↓
Randers et al 25 HomelessM27–47552312CG (n=10)82±42.8±0.860FG: 0.4 ↓*
CG: 0.1 ↑
FG: nc
CG: 0.1 ↓
FG: 0.08 ↑
CG: 0.1 ↑
FG: 0.1 ↓
CG: 0.1 ↑
FG: 0.1 ↑
CG: 0.2 ↓
Andersen et al 44 Healthy elderlyM63–7427116+46STG (n=9)
CG (n=8)
~801.7±0.360FG: nc
STG: 0.2 ↑
CG: 0.1↑
FG: 0.2 ↑
STG: 0.3↑
CG: nc
FG: nc
STG: 0.1 ↑
CG: 0.2 ↑
FG: 0.5 ↓
STG: 0.5↓
CG: 0.1↓
FG: nc
STG: 0.1↑
CG: 0.2↑
FG: 0.1↓
STG: 0.4 ↑
CG: nc
Krustrup et al 35 Mildly hypertensive middle-agedF45±5411052CG (n=12)~802.5±0.445–60FG: 0.1 ↓*
CG: 0.3 ↑
FG: 0.2 ↑*
CG: 0.2 ↓
FG: 0.1 ↓*
CG: 0.2 ↑
FG: nc
CG: 0.5 ↑
FG: 0.3 ↑
CG: 0.2 ↑
  • ↑*, significant increase; ↑, increase; ↓*, significant decrease; ↓, decrease.

  • CG, control group; F, female; FG, football group; HDL, high-density lipoprotein; HRmax, maximal heart rate; LDL, low-density lipoprotein; M, male; nc, no changes; RG, running group; STG, strength training group; ZG, Zumba group.